These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28654988)

  • 1. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration (Traditional Chinese Version).
    Cheng CW; Wu TX; Shang HC; Li YP; Altman DG; Moher D; Bian ZX;
    Ann Intern Med; 2017 Jul; 167(2):W7-W20. PubMed ID: 28654988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration (Simplified Chinese Version).
    Cheng CW; Wu TX; Shang HC; Li YP; Altman DG; Moher D; Bian ZX;
    Ann Intern Med; 2017 Jul; 167(2):W21-W34. PubMed ID: 28654957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration.
    Cheng CW; Wu TX; Shang HC; Li YP; Altman DG; Moher D; Bian ZX;
    Ann Intern Med; 2017 Jul; 167(2):112-121. PubMed ID: 28654980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Improving the quality of reporting Chinese herbal medicine trials: an elaborated checklist].
    Fei YT; Liu JP
    Zhong Xi Yi Jie He Xue Bao; 2008 Mar; 6(3):233-8. PubMed ID: 18334139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovation of clinical trials in China: Commentary on the publication of "CONSORT extension for Chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration".
    Wu T; Bian Z; Shang H; Li Y
    J Evid Based Med; 2017 Aug; 10(3):155-162. PubMed ID: 28857507
    [No Abstract]   [Full Text] [Related]  

  • 6. Improving the quality of randomized controlled trials in Chinese herbal medicine, part IV: applying a revised CONSORT checklist to measure reporting quality.
    Bian ZX; Moher D; Dagenais S; Li YP; Wu TX; Liu L; Miao JX; Song L; Zhang HM
    Zhong Xi Yi Jie He Xue Bao; 2006 May; 4(3):233-42. PubMed ID: 16696907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement.
    Gagnier JJ; Boon H; Rochon P; Moher D; Barnes J; Bombardier C;
    Ann Intern Med; 2006 Mar; 144(5):364-7. PubMed ID: 16520478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.
    Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
    Ann Intern Med; 2008 Feb; 148(4):295-309. PubMed ID: 18283207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
    Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
    Int J Surg; 2012; 10(1):28-55. PubMed ID: 22036893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.
    Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
    J Clin Epidemiol; 2010 Aug; 63(8):e1-37. PubMed ID: 20346624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reporting quality of randomized controlled trials in Chinese herbal medicine (CHM) formulas for diabetes based on the consort statement and its extension for CHM formulas.
    Liu Y; Hu C; Zhou K; Zhang Y; Kang J; Wen Y; Yuan R; Li J; Zhao Q; Zhang L; Yang X
    Front Pharmacol; 2024; 15():1288479. PubMed ID: 38318135
    [No Abstract]   [Full Text] [Related]  

  • 12. [Herbal CONSORT statement and standardization of reporting traditional Chinese drug trials].
    Fei YT; Liu JP
    Zhongguo Zhong Yao Za Zhi; 2008 Jan; 33(1):89-94. PubMed ID: 18338628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the quality of randomized controlled trials in Chinese herbal medicine, part III: quality control of Chinese herbal medicine used in randomized controlled trials.
    Leung KS; Bian ZX; Moher D; Dagenais S; Li YP; Liu L; Wu TX; Miao JX
    Zhong Xi Yi Jie He Xue Bao; 2006 May; 4(3):225-32. PubMed ID: 16696906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE): checklist with explanation and elaboration.
    Kwakkenbos L; Imran M; McCall SJ; McCord KA; Fröbert O; Hemkens LG; Zwarenstein M; Relton C; Rice DB; Langan SM; Benchimol EI; Thabane L; Campbell MK; Sampson M; Erlinge D; Verkooijen HM; Moher D; Boutron I; Ravaud P; Nicholl J; Uher R; Sauvé M; Fletcher J; Torgerson D; Gale C; Juszczak E; Thombs BD
    BMJ; 2021 Apr; 373():n857. PubMed ID: 33926904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for reporting randomized controlled trials of herbal interventions: Explanation and elaboration.
    Gagnier JJ; Boon H; Rochon P; Moher D; Barnes J; Bombardier C;
    J Clin Epidemiol; 2006 Nov; 59(11):1134-49. PubMed ID: 17027423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Better reporting of harms in randomized trials: an extension of the CONSORT statement.
    Ioannidis JP; Evans SJ; Gøtzsche PC; O'Neill RT; Altman DG; Schulz K; Moher D;
    Ann Intern Med; 2004 Nov; 141(10):781-8. PubMed ID: 15545678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the Consolidated Standards of Reporting Trials (CONSORT) checklist on reporting of randomized clinical trials in traditional Chinese medicine.
    Liu XT; Zhang X; Wen S; Peng L; Hong Q; Kang D
    J Evid Based Med; 2015 Nov; 8(4):192-208. PubMed ID: 26334556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The revised CONSORT statement for reporting randomized trials: explanation and elaboration.
    Altman DG; Schulz KF; Moher D; Egger M; Davidoff F; Elbourne D; Gøtzsche PC; Lang T;
    Ann Intern Med; 2001 Apr; 134(8):663-94. PubMed ID: 11304107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.
    Piaggio G; Elbourne DR; Altman DG; Pocock SJ; Evans SJ;
    JAMA; 2006 Mar; 295(10):1152-60. PubMed ID: 16522836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the quality of randomized controlled trials in Chinese herbal medicine, part I: clinical trial design and methodology.
    Bian ZX; Li YP; Moher D; Dagenais S; Liu L; Wu TX; Miao JX; Kwan AK; Song L
    Zhong Xi Yi Jie He Xue Bao; 2006 Mar; 4(2):120-9. PubMed ID: 16529686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.